Testicular cancer, malignant (ICD10 C62)
Five-year relative survival by diagnosis year and age at diagnosis
|
Five-year relative survival (with 95% confidence interval) by diagnosis year |
EUROCARE-4 |
EUROCARE-4 |
||||||||||
|
Age at diagnosis |
1994-97 |
1998-2002 |
2003-2007 |
2007-2009 |
##2000-2002 |
##2000-2002 |
||||||
|
cohort |
cohort |
cohort |
*hybrid |
Ireland |
Europe average |
|||||||
|
all 15-99 |
89.2% |
95.5% |
97.0% |
97.7% |
||||||||
|
(unstandardized) |
(82.5-92.3%) |
(93.2-97.0%) |
(95.0-98.3%) |
(95.8-98.9%) |
||||||||
|
all 15-64 |
87.9% |
94.9% |
97.0% |
97.4% |
- |
97.3% |
||||||
|
(age-standardized)# |
(84.8-98.5%) |
[sparse data] |
(96.4-98.2%) |
|||||||||
|
15-44 |
90.7% |
95.9% |
96.8% |
98.0% |
||||||||
|
(86.6-93.6%) |
(93.6-97.4%) |
(94.6-98.2%) |
(96.0-99.1%) |
|||||||||
|
45-54 |
83.4% |
90.9% |
95.2% |
91.3% |
||||||||
|
(65.2-93.2%) |
(76.3-97.1%) |
(84.8-98.7%) |
(75.7-97.3%) |
|||||||||
|
55-64 |
75.5% |
93.1% |
100.0% |
100.0% |
||||||||
|
(31.7-93.7%) |
(59.2-99.2%) |
- |
- |
|||||||||
|
Footnotes: |
|
|
*Hybrid estimate for 2007-2009 is the most up-to-date survival estimate and is based on follow-up of all cases alive at any point during this period, |
|
|
supplemented by follow-up 2005-2009 for cases diagnosed in 2005 or 2006 (to provide more reliable estimation of the first two years of survival). |
|
|
In practice, the hybrid estimate for 2007-2009 is similar to the most recent (incomplete) cohort, i.e. cases diagnosed 2003-2007, reflecting substantial overlap of data. |
|
|
# Age-standardized figures use the standard patient population proposed for this cancer by: |
|
|
Corazziari I., Quinn M. & Capocaccia R. 2004. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40: 2307-2316. |
|
|
(Population weights = age 15-44 x60000, 45-54 x10000, 55-64 x10000, total 80000 - other ages 65-99 excluded from age-standardized data for comparability with EUROCARE-4 results) |
|
|
## For comparison, the age-standardized average survival (2000-2002) is quoted for countries (including Ireland) that participated in the EUROCARE-4 study: |
|
|
Verdecchia A., Francisci S., Brenner H., et al. 2007. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8: 784-796. |
|
|
Exclusions (as in EUROCARE): |
|
|
Patients aged <15 or >99 at diagnosis; death-certificate-only (DCO) and autopsy-only cases; second or subsequent malignancies in the same patient |
|
|
(or the less serious of two or more synchronously-diagnosed malignancies); in situ carcinomas and tumours of uncertain behaviour. |
|
|
© National Cancer Registry Ireland 2011 (October 2011) Relative survival statistics for Irish cancer patients |
|